Cell counting market seen reaching $17.83 billion by 2030

The Business Research Company says the global cell counting market reached an estimated $11.39 billion in 2025 and is on track to hit $17.83 billion by 2030. Growth is being driven by chronic disease prevalence, life sciences research, and broader use of automated and AI-enabled lab tools.

Why it matters: - Cell counting sits at the center of research, diagnostics and therapeutic development, so faster market growth points to broader spending on precision lab tools. - Rising chronic disease cases are increasing demand for cell-based testing and monitoring. - The market’s move toward automation and AI could reshape laboratory workflows and improve consistency.

What happened: - The Business Research Company projected the global cell counting market will grow from an estimated $11.39 billion in 2025 to $12.49 billion in 2026. - The report said the market is expected to reach $17.83 billion by 2030. - The forecast implies a 9.7% CAGR from 2025 to 2026 and a 9.3% CAGR through 2030. - The company tied the outlook to life sciences growth, higher research activity and expanding lab automation.

The details: - Cell counting techniques are used to quantify cells in life science research, diagnostics and therapeutic development. - The methods help monitor cell health, measure proliferation and assess biological processes such as immortalization, transformation, transfection and infection. - Cell counting is also used to prepare cells for experiments and to support cell-based assays. - The report identified rising demand for cell-based therapies, precision diagnostics and biotech research pipelines as major growth drivers. - Increased use of AI-driven laboratory analytics and standardized lab workflows is also supporting market expansion. - Key trends include automated cell counting systems, flow cytometry applications, high-throughput counting and a stronger focus on accuracy and reproducibility. - The report said North America held the largest share of the market in 2025. - The report said Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report also covered South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report added new analytical tools for 2026, including market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables. - Download a free sample of the market report - View the full cell counting market report

Between the lines: - The forecast suggests buyers are prioritizing tools that can deliver faster and more reproducible cell analysis. - The regional outlook points to mature demand in North America and faster expansion in Asia-Pacific as biotech investment broadens. - The emphasis on AI and standardization indicates the market is shifting from standalone instruments toward integrated lab systems.

What's next: - The market’s growth path will likely track adoption of cell-based therapies, precision diagnostics and automated lab platforms. - Continued chronic disease prevalence could keep demand elevated for monitoring and diagnostic workflows. - The fastest gains may come from regions expanding biotech capacity and healthcare investment.

The bottom line: - Cell counting is moving from a research niche to a larger automation and analytics market, with the global category projected to add more than $6 billion by 2030.